Could Treatment Matching Patients’ Beliefs About Depression Improve Outcomes?

Jeffrey R. Vittengl, Lee Anna Clark, Michael E. Thase, Robin B Jarrett

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Patients’ beliefs about depression and expectations for treatment can influence outcomes of major depressive disorder (MDD) treatments. We hypothesized that patients with weaker biological beliefs (less endorsement of [a] biochemical causes and [b] need for medication) and more optimistic treatment expectations (greater improvement and shorter time to improvement), have better outcomes in cognitive therapy (CT). Outpatients with recurrent MDD who received acute-phase CT (N = 152), and a subset of partial or unstable responders (N = 51) randomized to 8 months of continuation CT or fluoxetine with clinical management, completed repeated measures of beliefs, expectations, and depression. As hypothesized, patients with weaker biological beliefs about depression, and patients who expected a shorter time to improvement, experienced greater change in depressive symptoms and more frequent response to acute-phase CT. Moreover, responders who received continuation treatment better matched to their biological beliefs (i.e., responders with weaker biological beliefs about depression who received continuation CT, or responders with stronger biological beliefs about depression who received continuation fluoxetine) had fewer depressive symptoms and less relapse/recurrence by 32 months after acute-phase CT than did responders who received mismatched continuation treatment. Specific screening and/or intervention targeting patients’ biological beliefs about depression could increase CT efficacy.

Original languageEnglish (US)
JournalBehavior Therapy
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Cognitive Therapy
Depression
Fluoxetine
Major Depressive Disorder
Therapeutics
Recurrence
Acute-Phase Reaction
Outpatients

Keywords

  • beliefs
  • cognitive therapy
  • depression
  • expectations
  • relapse

ASJC Scopus subject areas

  • Clinical Psychology

Cite this

Could Treatment Matching Patients’ Beliefs About Depression Improve Outcomes? / Vittengl, Jeffrey R.; Clark, Lee Anna; Thase, Michael E.; Jarrett, Robin B.

In: Behavior Therapy, 01.01.2019.

Research output: Contribution to journalArticle

@article{d44dfa6b16c24d9685c793128e565c0e,
title = "Could Treatment Matching Patients’ Beliefs About Depression Improve Outcomes?",
abstract = "Patients’ beliefs about depression and expectations for treatment can influence outcomes of major depressive disorder (MDD) treatments. We hypothesized that patients with weaker biological beliefs (less endorsement of [a] biochemical causes and [b] need for medication) and more optimistic treatment expectations (greater improvement and shorter time to improvement), have better outcomes in cognitive therapy (CT). Outpatients with recurrent MDD who received acute-phase CT (N = 152), and a subset of partial or unstable responders (N = 51) randomized to 8 months of continuation CT or fluoxetine with clinical management, completed repeated measures of beliefs, expectations, and depression. As hypothesized, patients with weaker biological beliefs about depression, and patients who expected a shorter time to improvement, experienced greater change in depressive symptoms and more frequent response to acute-phase CT. Moreover, responders who received continuation treatment better matched to their biological beliefs (i.e., responders with weaker biological beliefs about depression who received continuation CT, or responders with stronger biological beliefs about depression who received continuation fluoxetine) had fewer depressive symptoms and less relapse/recurrence by 32 months after acute-phase CT than did responders who received mismatched continuation treatment. Specific screening and/or intervention targeting patients’ biological beliefs about depression could increase CT efficacy.",
keywords = "beliefs, cognitive therapy, depression, expectations, relapse",
author = "Vittengl, {Jeffrey R.} and Clark, {Lee Anna} and Thase, {Michael E.} and Jarrett, {Robin B}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.beth.2018.11.007",
language = "English (US)",
journal = "Behavior Therapy",
issn = "0005-7894",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Could Treatment Matching Patients’ Beliefs About Depression Improve Outcomes?

AU - Vittengl, Jeffrey R.

AU - Clark, Lee Anna

AU - Thase, Michael E.

AU - Jarrett, Robin B

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Patients’ beliefs about depression and expectations for treatment can influence outcomes of major depressive disorder (MDD) treatments. We hypothesized that patients with weaker biological beliefs (less endorsement of [a] biochemical causes and [b] need for medication) and more optimistic treatment expectations (greater improvement and shorter time to improvement), have better outcomes in cognitive therapy (CT). Outpatients with recurrent MDD who received acute-phase CT (N = 152), and a subset of partial or unstable responders (N = 51) randomized to 8 months of continuation CT or fluoxetine with clinical management, completed repeated measures of beliefs, expectations, and depression. As hypothesized, patients with weaker biological beliefs about depression, and patients who expected a shorter time to improvement, experienced greater change in depressive symptoms and more frequent response to acute-phase CT. Moreover, responders who received continuation treatment better matched to their biological beliefs (i.e., responders with weaker biological beliefs about depression who received continuation CT, or responders with stronger biological beliefs about depression who received continuation fluoxetine) had fewer depressive symptoms and less relapse/recurrence by 32 months after acute-phase CT than did responders who received mismatched continuation treatment. Specific screening and/or intervention targeting patients’ biological beliefs about depression could increase CT efficacy.

AB - Patients’ beliefs about depression and expectations for treatment can influence outcomes of major depressive disorder (MDD) treatments. We hypothesized that patients with weaker biological beliefs (less endorsement of [a] biochemical causes and [b] need for medication) and more optimistic treatment expectations (greater improvement and shorter time to improvement), have better outcomes in cognitive therapy (CT). Outpatients with recurrent MDD who received acute-phase CT (N = 152), and a subset of partial or unstable responders (N = 51) randomized to 8 months of continuation CT or fluoxetine with clinical management, completed repeated measures of beliefs, expectations, and depression. As hypothesized, patients with weaker biological beliefs about depression, and patients who expected a shorter time to improvement, experienced greater change in depressive symptoms and more frequent response to acute-phase CT. Moreover, responders who received continuation treatment better matched to their biological beliefs (i.e., responders with weaker biological beliefs about depression who received continuation CT, or responders with stronger biological beliefs about depression who received continuation fluoxetine) had fewer depressive symptoms and less relapse/recurrence by 32 months after acute-phase CT than did responders who received mismatched continuation treatment. Specific screening and/or intervention targeting patients’ biological beliefs about depression could increase CT efficacy.

KW - beliefs

KW - cognitive therapy

KW - depression

KW - expectations

KW - relapse

UR - http://www.scopus.com/inward/record.url?scp=85060167942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060167942&partnerID=8YFLogxK

U2 - 10.1016/j.beth.2018.11.007

DO - 10.1016/j.beth.2018.11.007

M3 - Article

JO - Behavior Therapy

JF - Behavior Therapy

SN - 0005-7894

ER -